Prescribing aspirin to older people - where is the line between cardiovascular benefit and upper gastrointestinal bleeding risk?
Intern Med J
.
2022 Sep;52(9):1468-1470.
doi: 10.1111/imj.15905.
Authors
Oyekoya T Ayonrinde
1
2
3
,
Frank M Sanfilippo
4
5
,
Carl Schultz
2
6
Affiliations
1
Department of Gastroenterology and Hepatology, Fiona Stanley Hospital, Perth, Western Australia, Australia.
2
Medical School, The University of Western Australia, Perth, Western Australia, Australia.
3
Faculty of Health Sciences, Curtin University, Perth, Western Australia, Australia.
4
School of Population and Global Health, The University of Western Australia, Perth, Western Australia, Australia.
5
Pharmacy Department, Royal Perth Hospital, Perth, Western Australia, Australia.
6
Cardiology Department, Royal Perth Hospital, Perth, Western Australia, Australia.
PMID:
36100571
DOI:
10.1111/imj.15905
No abstract available
Publication types
Editorial
MeSH terms
Aged
Aspirin* / adverse effects
Gastrointestinal Hemorrhage* / chemically induced
Heart
Humans
Platelet Aggregation Inhibitors / adverse effects
Substances
Platelet Aggregation Inhibitors
Aspirin